New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia
Author:
Publisher
Edizioni Minerva Medica
Subject
General Medicine
Link
https://www.minervamedica.it/pdf.php?cod=R10Y2020N05A0478
Reference59 articles.
1. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia
2. Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
3. Genetic Basis of Acute Lymphoblastic Leukemia
4. Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia
5. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease;Leukemia;2023-08-28
2. Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin;Annals of Hematology;2021-07-31
3. Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies;Pediatric Drugs;2021-07-22
4. Acute leukemias in 2020: state of the art;Minerva Medica;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3